SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C18 - Vascular Cognitive Impairment and Dementia: Current Status and Future

Event Time: Saturday April 22, 2017 2:00 pm to 4:00 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Larry Goldstein MD, FAAN, FAHA
Description: Faculty will provide an overview of clinical science-related vascular cognitive impairment and dementia. An introduction to the overall status and challenges in the field will be followed by a review of current diagnostic strategies and treatment and potential future approaches. This program will conclude with a general summary and time-permitting case discussions.
Completion Message: Participants should be able to discuss diagnostic challenges, and current and possible future approaches to VCI/dementia.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Program Speakers - Tentative

Start/End Time Title Faculty
2:00 PM - 2:25 PM Vascular Cognitive Impairment/Dementia: Setting the Stage Larry Goldstein MD, FAAN, FAHA 
2:25 PM - 2:30 PM Questions and Answers Faculty 
2:30 PM - 3:05 PM Assessment and Diagnosis of Patients with Suspected VCI/Dementia David Knopman MD, FAAN 
3:05 PM - 3:10 PM Questions and Answers Faculty 
3:10 PM - 3:45 PM Current and Future Management of Patients with VCI/Dementia Gregory Jicha MD, PhD 
3:35 PM - 3:40 PM Questions and Answers Faculty 
3:40 PM - 4:00 PM Closing Remarks Faculty 


Speaker Disclosure
Larry B. Goldstein, MD, FAAN, FAHA Dr. Goldstein has received royalty, license fees, or contractual rights payments from Henry Stewart Talk and Up To Date.

Gregory A. Jicha, MD, PhD Alltech: Honoraria (scientific plenary). Abbvie, Alltech, Axovant, Esai, Janssen, Lilly, Suven, Toyama, Transtech Pharma.

David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck Pharmaceuticals and the DIAN study. Dr. Knopman has received research support from Biogen Pharmaceuticals and Lilly Pharmaceuticals.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C1 Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
9:30 AM-11:30 AM
C13 Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C10 More than Medicine: How to Access Home Care, Support Caregivers, and Discuss Complex Situations in Advanced Neurologic Disease Farrah Daly MD, MBA
1:30 PM-3:30 PM
C19 The Neurology of Social Behavior Bradford Dickerson MD

Sunday April 22, 2018

7:00 AM-9:00 AM
C32 Clinicopathological Correlation Session in Dementia David Irwin MD

Monday April 23, 2018

7:00 AM-9:00 AM
C66 Cognitive Impairment due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
1:00 PM-3:00 PM
C77 Present and Future Biomarkers in Dementia: A Case-based Approach Jonathan Graff-Radford MD
3:30 PM-5:30 PM
C91 Chronic Traumatic Encephalopathy: Update Andrew Budson MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C96 Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
1:00 PM-3:00 PM
N3 Neuroscience in the Clinic: Challenges in Genetic Diagnosis in Neurology Guy Rouleau MD, PhD,
Massimo Pandolfo MD, FAAN
C105 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C108 Neurologic Complications in Adults with Down Syndrome Andrea Gropman MD
3:30 PM-5:30 PM
C129 Disorders of Motor Programming: The Apraxias and Action-Intentional Disorders Chalk Talk Kenneth Heilman MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C134 Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C132 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD,MPH
C145 Non-Alzheimer's Dementia I: Frontotemporal Dementias Gil Rabinovici MD
3:30 PM-5:30 PM
C160 Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Gil Rabinovici MD

Friday April 27, 2018

7:00 AM-9:00 AM
C218 The Early-Onset Dementias Mario Mendez MD, PhD, FAAN
1:00 PM-3:00 PM
C226 Behavioral Neurology: A Case-based Approach A. Barrett MD, FAAN
3:30 PM-5:30 PM
C237 Memory Disorders: A Case-based Approach David Wolk MD


Forgot Password?